Cargando…
Evaluating the impact of price regulation (Drug Price Control Order 2013) on antibiotic sales in India: a quasi-experimental analysis, 2008–2018
BACKGROUND: In India, due to a lack of population-level financial risk protection mechanisms, the expenditure on healthcare is primarily out-of-pocket in nature. Through Drug Price Control Orders (DPCOs), the Indian Government attempts to keep medicine prices under check. The aim of this study was t...
Autores principales: | Selvaraj, Sakthivel, Farooqui, Habib Hasan, Mehta, Aashna, Mathur, Manu Raj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587621/ https://www.ncbi.nlm.nih.gov/pubmed/36273222 http://dx.doi.org/10.1186/s40545-022-00466-4 |
Ejemplares similares
-
Does price regulation affect atorvastatin sales in India? An impact assessment through interrupted time series analysis
por: Selvaraj, Sakthivel, et al.
Publicado: (2019) -
The impact of stringent prescription-only antimicrobial sale regulation (Schedule H1) in India: an interrupted time series analysis, 2008–18
por: Farooqui, Habib Hasan, et al.
Publicado: (2020) -
Impact of the Drug Prices Control Order (2013) on the Utilization of Anticancer Medicines in India: An Interrupted Time-Series Analysis
por: Sharma, Bhavna, et al.
Publicado: (2022) -
Community level antibiotic utilization in India and its comparison vis-à-vis European countries: Evidence from pharmaceutical sales data
por: Farooqui, Habib Hasan, et al.
Publicado: (2018) -
Outpatient antibiotic prescription rate and pattern in the private sector in India: Evidence from medical audit data
por: Farooqui, Habib Hasan, et al.
Publicado: (2019)